Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse

PURPOSE: Based on the tumor-promoting features of extracellular vesicles (EV) and PD-L1/2-bearing EV subpopulations (PD-L1/2(EV)), we evaluated their potential as surrogate markers for disease progression or eligibility criteria for PD-1 immune checkpoint inhibition (ICI) approaches in early triple-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Oliver, Wormland, Sebastian, Bittner, Ann-Kathrin, Collenburg, Monika, Horn, Peter A., Kimmig, Rainer, Kasimir-Bauer, Sabine, Rebmann, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984327/
https://www.ncbi.nlm.nih.gov/pubmed/35366112
http://dx.doi.org/10.1007/s00432-022-03980-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984327/
https://www.ncbi.nlm.nih.gov/pubmed/35366112
http://dx.doi.org/10.1007/s00432-022-03980-9

Ejemplares similares